The use of wearable technology in studies in older adults with cancer: a systematic review
AbstractBackground. Despite the increasing integration of wearable technology in oncology, its application in the care of older adults, representing most p
Related Articles
FDA Updates Fludarabine Phosphate Labeling in Chronic Lymphocytic Leukemia
The updated labeling also includes new information on the recommended dosage of fludarabine phosphate when given with cyclophosphamide and rituximab.
Moffit Celebrates Excellence in Nursing at the Annual Nurse of the Year Ceremony
Honoring five extraordinary nurses who inspire and uplift the Moffitt community
Fox Chase Cancer Center Researcher Lu Chen Receives $250,000 NIH Grant to Further Investigation of RNA
PHILADELPHIA (November 20, 2024) — Lu Chen, PhD, an Assistant Professor in the Nuclear Dynamics and Cancer Research Program and member of the Cancer Epigenetics…
UK SABR Consortium (@uksabr.bsky.social)
The SABR UK consortium’s official BlueSky account. Please follow us and share our BlueSky page! https://bsky.app/profile/uksabr.bsky.social
China’s NMPA Accepts sNDA for Penpulimab Plus Anlotinib for Advanced HCC
China’s NMPA has accepted a sNDA for penpulimab plus anlotinib for the first-line treatment of advanced hepatocellular carcinoma.
Volume 8 Issue 22 | Blood Advances | American Society of Hematology
Blood Advances | 8 | 22 | November 2024
Adding TTFields Upfront Improves PFS in Glioblastoma
Adding TTFields to first-line treatment with temozolomide and radiotherapy improved progression-free survival in patients with glioblastoma.
Patient-derived glioma organoids real time identification of IDH mutation, 1p/19q-codeletion and CDKN2A/B homozygous deletion with differential ion mobility spectrometry
Journal of Neuro-Oncology – Extent of brain tumor resection continues to be one of the central decisions taken during standard of care in glioma patients.…
Gastric Cancer Awareness Month: ‘Disturbing’ increase in metastatic cases among young adults
Gastric Cancer Awareness Month, observed every November, is intended to educate the public about the potential causes and risk factors for the disease.An estimated 27,000…
Fox Chase Cancer Center’s Dr. Richard J. Bleicher Appointed Vice Chair of the National Accreditation Program for Breast Centers and Chair of its Executive Committee
Richard J. Bleicher, MD, FACS, Chief of the Division of Breast Surgery and Clinical Director of the Breast Service Line at Fox Chase Cancer Center.